Skip to main navigation Skip to search Skip to main content

Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques

  • Helen L. Wu
  • , Kathleen Busman-Sahay
  • , Whitney C. Weber
  • , Courtney M. Waytashek
  • , Carla D. Boyle
  • , Katherine B. Bateman
  • , Jason S. Reed
  • , Joseph M. Hwang
  • , Christine Shriver-Munsch
  • , Tonya Swanson
  • , Mina Northrup
  • , Kimberly Armantrout
  • , Heidi Price
  • , Mitch Robertson-LeVay
  • , Samantha Uttke
  • , Mithra R. Kumar
  • , Emily J. Fray
  • , Sol Taylor-Brill
  • , Stephen Bondoc
  • , Rebecca Agnor
  • Stephanie L. Junell, Alfred W. Legasse, Cassandra Moats, Rachele M. Bochart, Joseph Sciurba, Benjamin N. Bimber, Michelle N. Sullivan, Brandy Dozier, Rhonda P. MacAllister, Theodore R. Hobbs, Lauren D. Martin, Angela Panoskaltsis-Mortari, Lois M.A. Colgin, Robert F. Siliciano, Janet D. Siliciano, Jacob D. Estes, Jeremy V. Smedley, Michael K. Axthelm, Gabrielle Meyers, Richard T. Maziarz, Benjamin J. Burwitz, Jeffrey J. Stanton, Jonah B. Sacha

Research output: Contribution to journalArticlepeer-review

Abstract

Allogeneic hematopoietic stem cell transplantation (alloHSCT) from donors lacking C-C chemokine receptor 5 (CCR5Δ32/Δ32) can cure HIV, yet mechanisms remain speculative. To define how alloHSCT mediates HIV cure, we performed MHC-matched alloHSCT in SIV+, anti-retroviral therapy (ART)-suppressed Mauritian cynomolgus macaques (MCMs) and demonstrated that allogeneic immunity was the major driver of reservoir clearance, occurring first in peripheral blood, then peripheral lymph nodes, and finally in mesenteric lymph nodes draining the gastrointestinal tract. While allogeneic immunity could extirpate the latent viral reservoir and did so in two alloHSCT-recipient MCMs that remained aviremic >2.5 years after stopping ART, in other cases, it was insufficient without protection of engrafting cells afforded by CCR5-deficiency, as CCR5-tropic virus spread to donor CD4+ T cells despite full ART suppression. These data demonstrate the individual contributions of allogeneic immunity and CCR5 deficiency to HIV cure and support defining targets of alloimmunity for curative strategies independent of HSCT.

Original languageEnglish (US)
Pages (from-to)1649-1663.e5
JournalImmunity
Volume56
Issue number7
DOIs
StatePublished - Jul 11 2023

Bibliographical note

Publisher Copyright:
© 2023 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CCR5
  • GVHD
  • HIV
  • HSCT
  • SIV

Fingerprint

Dive into the research topics of 'Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques'. Together they form a unique fingerprint.

Cite this